222 related articles for article (PubMed ID: 29759329)
41. The role of vaginal brachytherapy in the treatment of surgical stage I papillary serous or clear cell endometrial cancer.
Barney BM; Petersen IA; Mariani A; Dowdy SC; Bakkum-Gamez JN; Haddock MG
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):109-15. PubMed ID: 22543202
[TBL] [Abstract][Full Text] [Related]
42. Evaluating adjacent organ radiation doses from postoperative intracavitary vaginal vault brachytherapy for endometrial cancer.
Caon J; Holloway C; Dubash R; Yuen C; Aquino-Parsons C
Brachytherapy; 2014; 13(1):94-9. PubMed ID: 24269147
[TBL] [Abstract][Full Text] [Related]
43. The effect of pelvic radiotherapy on vaginal brachytherapy cylinder diameter: Implications for optimal treatment order.
Rakhra SS; Weaver C; Donnelly ED; Helenowski I; Prescott AE; Strauss JB
Brachytherapy; 2016; 15(5):549-53. PubMed ID: 27317190
[TBL] [Abstract][Full Text] [Related]
44. Intravaginal high-dose-rate brachytherapy for stage I endometrial cancer: a randomized study of two dose-per-fraction levels.
Sorbe B; Straumits A; Karlsson L
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1385-9. PubMed ID: 16029797
[TBL] [Abstract][Full Text] [Related]
45. The role of vaginal cuff brachytherapy in endometrial cancer.
Harkenrider MM; Block AM; Siddiqui ZA; Small W
Gynecol Oncol; 2015 Feb; 136(2):365-72. PubMed ID: 25555710
[TBL] [Abstract][Full Text] [Related]
46. Image-based multichannel vaginal cylinder brachytherapy for the definitive treatment of gynecologic malignancies in the vagina.
Gebhardt BJ; Vargo JA; Kim H; Houser CJ; Glaser SM; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Courtney-Brooks M; Beriwal S
Gynecol Oncol; 2018 Aug; 150(2):293-299. PubMed ID: 29929925
[TBL] [Abstract][Full Text] [Related]
47. Late reactions after postoperative high-dose-rate intravaginal brachytherapy for endometrial cancer: a comparison of standardized and individualized target volumes.
Onsrud M; Strickert T; Marthinsen AB
Int J Radiat Oncol Biol Phys; 2001 Mar; 49(3):749-55. PubMed ID: 11172958
[TBL] [Abstract][Full Text] [Related]
48. Intravaginal brachytherapy in FIGO stage I low-risk endometrial cancer: a controlled randomized study.
Sorbe B; Nordström B; Mäenpää J; Kuhelj J; Kuhelj D; Okkan S; Delaloye JF; Frankendal B
Int J Gynecol Cancer; 2009 Jul; 19(5):873-8. PubMed ID: 19574776
[TBL] [Abstract][Full Text] [Related]
49. Three-dimensional-printed vaginal applicators for electronic brachytherapy of endometrial cancers.
Lee JH; Kim HN; Lim HS; Cho SO
Med Phys; 2019 Feb; 46(2):448-455. PubMed ID: 30548607
[TBL] [Abstract][Full Text] [Related]
50. Economic impact of decreasing the fraction number in vaginal cuff brachytherapy: A direct cost analysis.
Zhang Y; Rovirosa A; Ascaso C; Herreros A; Torne A; Li Y; Biete A; Sánchez J
Brachytherapy; 2020; 19(1):60-65. PubMed ID: 31587986
[TBL] [Abstract][Full Text] [Related]
51. Dosimetric analysis of rectal filling on rectal doses during vaginal cuff brachytherapy.
Sabater S; Arenas M; Berenguer R; Machin-Hamalainen S; Andres I; Sevillano MM; Jimenez-Jimenez E; Martos A; Lopez-Honrubia V; Fernandez-Lopez J
Brachytherapy; 2015; 14(4):458-63. PubMed ID: 25900391
[TBL] [Abstract][Full Text] [Related]
52. Triple-tandem high-dose-rate brachytherapy for early-stage medically inoperable endometrial cancer: Initial report on acute toxicity and dosimetric comparison to stereotactic body radiation therapy.
Kauffmann G; Wu T; Al-Hallaq H; Hasan Y
Brachytherapy; 2017; 16(1):141-146. PubMed ID: 27866953
[TBL] [Abstract][Full Text] [Related]
53. Intravaginal 1-week high-dose-rate brachytherapy alone for Stages I-II endometrial cancer.
Martínez-Monge R; Nagore G; Cambeiro M; Garrán C; Villafranca E; Jurado M
Brachytherapy; 2007; 6(3):195-200. PubMed ID: 17681240
[TBL] [Abstract][Full Text] [Related]
54. MRI-Based Evaluation of the Vaginal Cuff in Brachytherapy Planning: Are We Missing the Target?
Chapman CH; Prisciandaro JI; Maturen KE; Cao Y; Balter JM; McLean K; Jolly S
Int J Radiat Oncol Biol Phys; 2016 Jun; 95(2):743-50. PubMed ID: 27020110
[TBL] [Abstract][Full Text] [Related]
55. First clinical implementation of the Capri applicator.
Gloi AM
J Appl Clin Med Phys; 2014 Jan; 15(1):4581. PubMed ID: 24423857
[TBL] [Abstract][Full Text] [Related]
56. A dosimetric analysis of intensity-modulated radiation therapy (IMRT) as an alternative to adjuvant high-dose-rate (HDR) brachytherapy in early endometrial cancer patients.
Aydogan B; Mundt AJ; Smith BD; Mell LK; Wang S; Sutton H; Roeske JC
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):266-73. PubMed ID: 16618581
[TBL] [Abstract][Full Text] [Related]
57. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
Alektiar KM; Venkatraman E; Chi DS; Barakat RR
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):111-7. PubMed ID: 15850910
[TBL] [Abstract][Full Text] [Related]
58. Clinical applications of custom-made vaginal cylinders constructed using three-dimensional printing technology.
Sethi R; Cunha A; Mellis K; Siauw T; Diederich C; Pouliot J; Hsu IC
J Contemp Brachytherapy; 2016 Jun; 8(3):208-14. PubMed ID: 27504130
[TBL] [Abstract][Full Text] [Related]
59. Postoperative vaginal cuff irradiation using high dose rate remote afterloading: a phase II clinical protocol.
Noyes WR; Bastin K; Edwards SA; Buchler DA; Stitt JA; Thomadsen BR; Fowler JF; Kinsella TJ
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1439-43. PubMed ID: 7635785
[TBL] [Abstract][Full Text] [Related]
60. [High dose rate vaginal brachytherapy in endometrial cancer after surgery].
Moreau-Claeys MV; Brunaud C; Hoffstetter S; Buchheit I; Peiffert D
Cancer Radiother; 2011 Jun; 15(3):169-75. PubMed ID: 21237693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
